Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,586 recalls · Class II, newest first

Class II · Moderate risk

Nucala (mepolizumab)

Temperature Abuse; Product stored and shipped outside of labeled storage requirements.

Terminated Temperature excursion Cardinal Health dba Specialty Pharmaceutical Services NDC 0173-0892-42 D-1876-2019
Class II · Moderate risk

Anagrelide Capsules

Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.

Terminated Impurity / degradation Torrent Pharma Inc. NDC 13668-453-01 D-1862-2019

Recalls by year